Global MarketsIMPORTANTJuly 15 at 11:50 AM

Novo Nordisk (NOVOB DC) receives European Commission approval of Wegovy pill as first Oral-GLP 1 for weight management in the EU; ready-to-use pen for higher dose 7.2mg also approved

StockNow breaking-news AI analysis

The EC approved Wegovy's oral pill and 7.2mg pen. Clinical trials show high efficacy. Launches are set for Q3 and H2 2026, targeting new users and dose escalation.

1 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

Geopolitics

Gulf official tells CNN “50:50” chance US and Iran could reach deal by Friday, CNN reports; Iranian delegation does not include IRGC, which would need to sign off on details of provisional agreement

Geopolitics

The draft agreed to by Iranian and Omani negotiators awaits final approval from Iran’s supreme leader, two regional officials told The Associated Press on Wednesday

U.S. Economy